HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.
![handle is hein.congrecreports/crptxadlv0001 and id is 1 raw text is: AUTHENTICATED
U.S. GOVERNMENT
INFORMATION .
116TH CONGRESS REPORT
2d Session HOUSE OF REPRESENTATIVES 116-573
MAKING OBJECTIVE DRUG EVIDENCE REVISIONS FOR
NEW LABELING ACT OF 2020
NOVEMBER 16, 2020.-Committed to the Committee of the Whole House on the
State of the Union and ordered to be printed
Mr. PALLONE, from the Committee on Energy and Commerce,
submitted the following
R E P O R T
[To accompany H.R. 5668]
[Including cost estimate of the Congressional Budget Office]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 5668) to amend the Federal Food, Drug, and Cos-
metic Act to modernize the labeling of certain generic drugs, and
for other purposes, having considered the same, reports favorably
thereon with an amendment and recommends that the bill as
amended do pass.
CONTENTS
Page
I. Purpose and Sum m ary ............................................................................. 4
II. Background and Need for the Legislation .............................................. 4
III. Com m ittee H earings ................................................................................. 5
IV . Com m ittee Consideration ......................................................................... 6
V . C om m ittee V otes ....................................................................................... 6
V I. O versight Findings .................................................................................... 6
VII. New Budget Authority, Entitlement Authority, and Tax Expenditures 6
VIII. Congressional Budget Office Estimate ...................................................... 7
IX. Federal M andates Statem ent ................................................................... 8
X. Statement of General Performance Goals and Objectives ....................... 8
XI. Duplication of Federal Program s ............................................................. 8
XII. Committee Cost Estimate .......................................................................... 8
XIII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits ............... 8
XIV. Advisory Com m ittee Statem ent ............................................................... 8
XV. Applicability to Legislative Branch ........................................................... 9
XVI. Section-by-Section Analysis of the Legislation ......................................... 9
XVII. Changes in Existing Law Made by the Bill, as Reported ....................... 11
19-006](ViewImageLocal?handle=hein.congrecreports/crptxadlv0001&div=1&collection=&method=preview&ext=.png&size=3)